Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 42,459 | 71,407 | 46,186 | 24,382 | 23,849 |
| Depreciation Amortization | 16,511 | 15,286 | 13,567 | 9,964 | 8,688 |
| Income taxes - deferred | -1,101 | -3,835 | 760 | -817 | -300 |
| Accounts receivable | 4,564 | -12,766 | -971 | -2,215 | -4,370 |
| Accounts payable and accrued liabilities | 1,038 | 6,346 | 7,248 | -2,315 | 4,124 |
| Other Working Capital | 7,592 | -19,240 | -10,046 | -1,237 | -852 |
| Other Operating Activity | 11,298 | 9,667 | -8,768 | 8,413 | 3,648 |
| Operating Cash Flow | $82,361 | $66,865 | $47,976 | $36,175 | $34,787 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,615 | -18,312 | -3,299 | -3,128 | -4,201 |
| Net Acquisitions | -3,750 | -18,585 | -51,299 | -45,324 | N/A |
| Other Investing Activity | 1,250 | -3,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-11,115 | $-40,397 | $-54,598 | $-48,452 | $-4,201 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 10,000 | 50,000 | 75,824 | N/A |
| Debt Repayment | N/A | N/A | N/A | -50,250 | -4,500 |
| Common Stock Issued | 2,450 | 3,052 | 3,559 | 443 | 183 |
| Dividend Paid | N/A | N/A | N/A | -10,612 | -21,170 |
| Other Financing Activity | -36,753 | -44,121 | -57,116 | -489 | -2,110 |
| Financing Cash Flow | $-34,303 | $-31,069 | $-3,557 | $14,916 | $-27,597 |
| Exchange Rate Effect | -5,261 | 858 | 1,296 | -1,005 | -298 |
| Beginning Cash Position | 49,771 | 53,514 | 62,397 | 60,763 | 58,072 |
| End Cash Position | 81,453 | 49,771 | 53,514 | 62,397 | 60,763 |
| Net Cash Flow | $31,682 | $-3,743 | $-8,883 | $1,634 | $2,691 |
| Free Cash Flow | |||||
| Operating Cash Flow | 82,361 | 66,865 | 47,976 | 36,175 | 34,787 |
| Capital Expenditure | -8,615 | -18,312 | -3,299 | -3,797 | -4,201 |
| Free Cash Flow | 73,746 | 48,553 | 44,677 | 32,378 | 30,586 |